Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony

Contrasts EsoCheck's powerful cell collection capabilities to cruder, decades-old technologies during comments on patient access to medical technology innovation
NEW YORK, Feb. 15, 2024 /PRNewswire/...

Related Keywords

Lishan Aklog ,Lucid Diagnostics Inc ,Nasdaq ,Exchange Commission ,National Cancer Institute Betrnet ,Case Western Reserve University ,Pavmed Inc ,Contrasts Esocheck ,Lucid Diagnostics ,Chief Executive Officer ,Cell Collection Device ,Representative Committee ,Brillo Pad Like ,Digestive Disease Week ,National Cancer Institute ,Trefoil Factor ,Esocheck Esophageal Cell Collection Device ,Annual Report ,Quarterly Report ,Markets ,